ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

HUAWEI reveals its first continuous glucose monitor, the Sence G1, in China on November 13, 2026. The device, approved by China's National Medical Products Administration on October 30, is the company's first Class III medical device. Development began in December 2023, and the sensor offers a lag time of 5 to 15 minutes with a MARD of less than 10%.
Tap to vote and see what everyone thinks.
Summary by ByteBrief